We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Timing of Repeated Lactate Measurement in Patients With Septic Shock at the Emergency Department.
American Journal of the Medical Sciences 2018 August
BACKGROUND: The objective of this study was to evaluate the prognostic value of lactate levels during the first 12 hours after shock development and to identify the optimal timing for repeated lactate measurements in patients with septic shock.
METHODS: We conducted a retrospective cohort study using a prospective data registry, and enrolled 2,226 consecutive adult patients with septic shock between January 2010 and December 2015. Blood lactate was measured at shock development, and after 2, 4, 6 and 12 hours (T0 , T2 , T4 , T6 and T12 ) during protocol-driven resuscitation bundle therapy. The prognostic value of lactate levels for 28-day mortality was analyzed using logistic regression and receiver operating characteristic curve analysis.
RESULTS: A total of 829 patients with septic shock were included in the study, among whom 211 died during the study period. The lactate levels at each time point were associated with increased 28-day mortality, and the lactate level at 6 hours had the greatest prognostic value (area under the curve of T0 = 0.61; T2 = 0.65; T4 = 0.69; T6 = 0.72 and T12 = 0.62, and odds ratio (OR) of T0 , 1.17 [95% CI: 1.11-1.23]; T2 , 1.23 [95% CI: 1.17-1.30]; T4 , 1.30 [95% CI: 1.22-1.38]; T6 , 1.33 [95% CI: 1.26-1.42] and T12 , 1.24 [95% CI: 1.19-1.30]). Hyperlactatemia over 2mmol/L and 4mmol/L at 6 hours from shock was associated with 4-times higher mortality (≥2mmol/L, OR = 3.89 [95% CI: 2.48-6.09]; ≥4mmol/L, OR = 3.93 [95% CI: 2.83-5.44]).
CONCLUSIONS: During the first 12 hours following shock development, the optimal time point of repeated blood lactate measurement was 6 hours, which was the greatest prognostic value for mortality.
METHODS: We conducted a retrospective cohort study using a prospective data registry, and enrolled 2,226 consecutive adult patients with septic shock between January 2010 and December 2015. Blood lactate was measured at shock development, and after 2, 4, 6 and 12 hours (T0 , T2 , T4 , T6 and T12 ) during protocol-driven resuscitation bundle therapy. The prognostic value of lactate levels for 28-day mortality was analyzed using logistic regression and receiver operating characteristic curve analysis.
RESULTS: A total of 829 patients with septic shock were included in the study, among whom 211 died during the study period. The lactate levels at each time point were associated with increased 28-day mortality, and the lactate level at 6 hours had the greatest prognostic value (area under the curve of T0 = 0.61; T2 = 0.65; T4 = 0.69; T6 = 0.72 and T12 = 0.62, and odds ratio (OR) of T0 , 1.17 [95% CI: 1.11-1.23]; T2 , 1.23 [95% CI: 1.17-1.30]; T4 , 1.30 [95% CI: 1.22-1.38]; T6 , 1.33 [95% CI: 1.26-1.42] and T12 , 1.24 [95% CI: 1.19-1.30]). Hyperlactatemia over 2mmol/L and 4mmol/L at 6 hours from shock was associated with 4-times higher mortality (≥2mmol/L, OR = 3.89 [95% CI: 2.48-6.09]; ≥4mmol/L, OR = 3.93 [95% CI: 2.83-5.44]).
CONCLUSIONS: During the first 12 hours following shock development, the optimal time point of repeated blood lactate measurement was 6 hours, which was the greatest prognostic value for mortality.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app